arrow
H

Hitoshi Maruyama

department of gastroenterology
H指数:38
被引数:6,614

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of New Hepatic Arterial Infusion Chemotherapy with Lipiodol, a New-FP Therapy for Unresectable Advanced Intrahepatic Cholangiocarcinoma (iCCA)

新型肝动脉灌注化疗联合碘油(Lipiodol)的新FP疗法对不可切除性进展期肝内胆管癌(iCCA)的疗效

2026-01-010
PRE
Management of acute variceal bleeding: updated APASL guidelines

急性静脉曲张出血的管理:APASL指南更新

2025-08-310
PRE
Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma

亚洲肿瘤消融会议肝细胞癌指南

2025-03-030
OA
Use of albumin infusion for cirrhosis-related complications: An international position statement
2023-08-0120
OAAI
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
2022-01-0111
OAAI
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma
2021-12-0634
OA
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
2021-11-0124
OAAI
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

来伐替尼在晚期肝细胞癌患者中的后处理

2021-04-2027
OAAI
The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
2021-03-0530
OAAI
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
2021-01-0112
OAAI
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
2020-07-2215
OAAI